![Robert John](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert John
Corporate Officer/Principal bij
CVRX, INC.
Vermogen: 54 662 $ op 31-05-2026
Profiel
Robert John is currently Chief Revenue Officer at CVRx, Inc. since 2024.
Formerly, Mr. John was General Manager-Cardiac Rhythm Management EMEA at Abbott Laboratories from 2008 to 2023.
Education includes graduate studies at The University of Alabama and undergraduate studies at the University of North Texas.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CVRX, INC. 0,04% | 06-04-2026 | 9.796 ( 0,04% ) | 54 662 $ | 31-05-2026 |
Actieve functies van Robert John
| Bedrijven | Functie | Begin |
|---|---|---|
| CVRX, INC. | Corporate Officer/Principal | 27-06-2024 |
Eerdere bekende functies van Robert John
| Bedrijven | Functie | Einde |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01-01-2023 |
Opleiding van Robert John
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
72
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
The University of Alabama
 The University of Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of North Texas
 University of North Texas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CVRx, Inc.
 CVRx, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes neuromodulation device & implantable technology to treat hypertension and heart failure | Health Technology |
